HPV Living Evidence Partnership
Taking the next steps to eliminate cervical cancer
We’re working with governments across Africa to improve coverage of the life-saving HPV vaccine for young women and girls in low- and middle-income countries (LMICs).
Challenge
Bringing a life-saving vaccine to those who need it most
Cervical cancer is a leading cause of cancer death for women in LMICs. Despite the availability of a safe, effective, single-dose HPV vaccine, coverage in these areas remains critically low due to delivery challenges.
Those working to improve HPV vaccine roll-out are asking the same questions in different contexts, like:
Delivery strategies
What delivery strategies work best in schools and/or rural areas?
Trust building
How do we build trust, demand, and uptake in underserved communities?
Best practices
What are best practices related to timing, messaging, and coordination?
The HPV Living Evidence Partnership is identifying evidence-based approaches that address these challenges and drive high, sustainable, equitable coverage of HPV vaccination.
Evidence resources
A dynamic evidence system made for decision-makers
Explore the evidence repository, interactive maps and research documents supporting HPV vaccine delivery.
Leadership
Country leaders are at the heart of our partnerships
Steering Group
Country decision-makers, implementers, and technical leads who define our priorities and shape how we package and share evidence.
Advisory Group
Global technical and delivery experts who ensure our work is aligned, high-quality, and relevant.
Join us in this vital work
Are you working on HPV vaccine coverage as a…
Country team
with pressing delivery questions?
Synthesis Group
ready to contribute to living reviews?
Funder or partner
supporting HPV vaccine programs?
We’re onboarding new country partners as we grow this project. Reach out to Fumane Lekoala at hello@aliveevidence.org for more information.
Alive Newsletter
Stay connected to Alive
